Experiences of Latent Tuberculosis Infection Treatment for the North Korean Refugees |
Kim, Beong Ki
(Division of Pulmonary, Sleep and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine)
Kim, Hee Jin (Korea Institute of Tuberculosis) Kim, Ho Jin (Division of Pulmonary, Sleep and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine) Cha, Jae Hyung (Medical Science Research Center, Korea University Ansan Hospital, Korea University College of Medicine) Lee, Jin Beom (Korea Institute of Tuberculosis) Jeon, Jeonghe (Settlement Support Center for North Korean Refugees (Hanawon)) Kim, Chi Young (Division of Pulmonary, Sleep and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine) Kim, Young (Division of Pulmonary, Sleep and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine) Kim, Je Hyeong (Division of Pulmonary, Sleep and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine) Shin, Chol (Division of Pulmonary, Sleep and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine) Lee, Seung Heon (Division of Pulmonary, Sleep and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine) |
1 | Choi CM, June JH, Kang CI, Park JT, Oh SY, Lee JB, et al. Tuberculosis among dislocated North Koreans entering Republic of Korea since 1999. J Korean Med Sci 2007;22:963-7. DOI |
2 | Ann SY, Ryou SH, Kim SB. Clinical characteristics of defectors from North Korea visiting a single tertiary hospital in South Korea. Korean J Med 2015;89:54-63. DOI |
3 | Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-204. |
4 | Joint Committee for the Revision of Korean Guidelines for Tuberculosis; Korean Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 3rd ed. Cheonju: Korea Centers for Disease Control and Prevention; 2017. |
5 | Fox GJ, Dobler CC, Marais BJ, Denholm JT. Preventive therapy for latent tuberculosis infection-the promise and the challenges. Int J Infect Dis 2017;56:68-76. DOI |
6 | Chen S, Zhang H, Pan Y, Long Q, Xiang L, Yao L, et al. Are free anti-tuberculosis drugs enough? An empirical study from three cities in China. Infect Dis Poverty 2015;4:47. DOI |
7 | Venkatesan P. Changing the treatment landscape for latent tuberculosis with rifampicin. Lancet Respir Med 2018;6:740. DOI |
8 | Menzies D, Adjobimey M, Ruslami R, Trajman A, Sow O, Kim H, et al. Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults. N Engl J Med 2018;379:440-53. DOI |
9 | Lee SH, Lew WJ, Kim HJ, Lee HK, Lee YM, Cho CH, et al. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Respir Med 2010;104:448-53. DOI |
10 | Korea Centers for Disease Control and Prevention. Annual report on the notified tuberculosis in Korea, 2018 [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2019 [cited 2019 Apr 30]. Available from: http://tbzero.cdc.go.kr/tbzero/board/boardView.do?leftMenuId=48¶mMenuId=77&boardSeq=5464&crudType=R. |
11 | World Health Organization. Implementing the end TB strategy: the essentials. WHO/HTM/TB [Internet]. Geneva: World Health Organization; 2015 [cited 2019 Apr 30]. Available from: https://www.who.int/tb/publications/2015/The_Essentials_to_End_TB/en/. |
12 | Cho KS. Tuberculosis control in the Republic of Korea. Epidemiol Health 2018;40:e2018036. DOI |
13 | Min GH, Kim Y, Lee JS, Oh JY, Hur GY, Lee YS, et al. Social and clinical characteristics of immigrants with tuberculosis in South Korea. Yonsei Med J 2017;58:592-7. DOI |
14 | Lee S, Ryu JY, Kim DH. Pre-immigration screening for tuberculosis in South Korea: a comparison of smear- and culturebased protocols. Tuberc Respir Dis 2019;82:151-7. DOI |
15 | Assefa Y, Assefa Y, Woldeyohannes S, Hamada Y, Getahun H. 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review. Eur Respir J 2018;52:1800395. DOI |
16 | Lee SH, Yim JJ, Kim HJ, Shim TS, Seo HS, Cho YS, et al. Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak. Epidemiol Infect 2012;140:1028-35. DOI |
17 | Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest 2009;135:1010-8. DOI |
18 | Seung KJ, Linton SW. The growing problem of multidrugresistant tuberculosis in North Korea. PLoS Med 2013;10:e1001486. DOI |
19 | Kim YN. Narrative Inquiry about entering process South Korea, NIS investigation course and Hanawon center curriculum of North Korean defectors. J Hum Rights Law-Relat Educ Res 2016;9:33-64. |
20 | Park SJ, Jo KW, Yoo B, Lee CK, Kim YG, Yang SK, et al. Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy. Int J Tuberc Lung Dis 2015;19:342-8. DOI |
21 | Park SM, Lee HW. Current status of healthcare and effective health aid strategies in North Korea. J Korean Med Assoc 2013;56:368-74. DOI |